Assignee
CELLACT PHARMA GMBH
DE4 patents
Top patents by PatentIndex Score
US7794715B2Sep 14, 2010
Anti-TIRC7 antibodies in therapy of inflammatory diseases
CELLACT PHARMA GMBH3 citations59
US11892454B2Feb 6, 2024
Method for the diagnosis of etoposide prodrug treatable cancer
CELLACT PHARMA GMBH0 citations48
US10183035B2Jan 22, 2019
Etoposide and prodrugs thereof for use in targeting cancer stem cells
CELLACT PHARMA GMBH0 citations48
US9827261B2Nov 28, 2017
Etoposide and prodrugs thereof for use in targeting cancer stem cells
CELLACT PHARMA GMBH1 citations48